Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
These are uncommon at standard therapeutic doses and typically indicate the dose needs adjustment
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
Robust quality-assurance program with in-house analytical lab performing identity, potency, and sterility testing
doi: 10.1111/obr.13372 42 NauckMABartelsEOrskovCEbertRCreutzfeldtW
US$ 25.82
US$ 26.39
US$ 25.37
